Author Archives: Ryan Barnes

Don't Fight the Tape

Don’t Fight the Tape: Cannabis Stocks Subject to Broad Market Swings

Don’t Fight the Tape: Cannabis Stocks Subject to Broad Market Swings

Investors may be lulled into thinking that stocks they own or study in the cannabis space are insulated from what’s happening in the broader market. But that’s simply not true, and violates one of the oldest maxims in investing: Don’t fight the tape.

Medicine Man

Medicine Man Technologies Files Pre-IPO Documents with SEC

Ownership in the Medicine Man Denver stores—there are two now, one near the airport in Denver and one in Aurora—is not actually what is being pitched to investors in the S-1 from Medicine Man Technologies. The business of Medicine Man Technologies is actually consulting, but its model and outlook are inexorably tied to the highly successful cultivator and retailer you may have seen on MSNBC’s “Pot Barons” TV series.

Zynerba IPO

Zynerba IPO a Big $275 Million Entry for Cannabinoids

It has been a bit of a dry spell for decent IPOs in the cannabis space. But the rains have come down with the initial public offering of Devon, Pennsylvania-based Zynerba Pharmaceuticals (NASDAQ: ZYNE).

Conference Call

Prepping for MassRoots’ Shareholder Conference Call

It has been a couple of months since MassRoots (OTCQB: MSRT) became a publicly-traded company. Since that time, the company has struggled to see its share price break above the original offering price.

MyDx CannaDx

MyDx Looks to Crack Open the Green Leaf

MyDx’s hardware/software ecosystem has a very easy value proposition to dish out: simple, instant testing of solids, liquids and gases to measure their positive attributes, and whether there’s any pesticides or other no-gooders in your food, water and air.


Tweed Buys Out Bedrocan in M&A Opening Salvo

On June 24, 2015, it was announced that two of the biggest brands in the burgeoning Canadian cannabis market are about be under one roof. Tweed Marijuana Inc. (TSXV: TWD) has agreed to acquire all the outstanding shares of Bedrocan Canada (TSXV: BED).


Cannabis in Canada: A Data Snapshot

The evolution of the cannabis market in Canada continues to be a crucial case study. There is a lot we can learn about how business models are taking shape and the headwinds being faced in the legalized medical environment that the Canadian MMPR provides.

Lloyd's of London

Lloyd’s of London Takes Back Vote of Cannabis Confidence

On May 29, 2015, Marijuana Business Daily reported that it had viewed a memo from insurance behemoth Lloyd’s of London, wherein it directs its underwriters not to write or renew existing policies to cannabis-based companies until the plant is legal on the federal level.

private placement

On Private Vs. Public Companies, Unicorns and Cannabis

Would you like to invest in Uber? Or how about Airbnb? Well it turns out that you can’t. If you’re a regular Joe or Jane investor, there are no shares to buy for either company, or for companies like Pinterest and SpaceX.


Are Cannabis Stocks Riding a Market Wave?

In the past few weeks we have seen some massive volatility in the most active cannabis stocks. At the same time we have seen broad market indexes like the NASDAQ and the S&P 500 hit new record highs, begging the question of whether the cannabis stocks are just following general momentum.

Fred Gross and Cannafundr

Fred Gross and Cannafundr Raising Cannabis Capital

Every industry is only as strong as the connection between the capital needed to grow and maintain it, and the companies themselves, who allocate that capital to expand new markets, lower costs, add services and improve product offerings.


Fascinating Case Study Begins April 9 as MassRoots Goes Public

MassRoots, which will begin trading on or around April 9, 2015, under the ticker MSRT, is set to be the first public cannabis company with a revenue model and a customer acquisition strategy built entirely around social media platforms.


The S-1 Review: Framing Filings and Federal Changes

Today we’ll be looking under the hood of two more companies, but before we do it’s worth spending a moment to take note of how the cannabis industry could be massively reframed as a result of recent news out of Washington, D.C.

public offering

A Look Inside the S-1s of Upcoming Public Offerings

There are many early-stage companies with an eye on cannabis that are entering the publicly-traded space these days. We wanted to give you a brief overview of some of the companies that are likely to offer public securities for the first time in 2015.

Investor Protection in US and Canada

Investor Protection Moves in the US and Canada

It has been a noteworthy past few days in the realm of investors’ rights. Two different stories that may seem completely unrelated are sewn with some of the same thread, especially for investors that are actively looking at the cannabis space.

stock forecast

What the 5 Largest Cannabis Stocks Can Tell Us

The early leaders in market cap (the total value of publicly-traded equity) in a expanding industry like cannabis can tell us a lot. These companies have a lot of advantages by being on this perch, but also some responsibilities.